Downregulation of beclin1 and LC3 mRNA and protein expression is observed in response to the BV6 in combination with TRAIL and TNFα in both MCF7 and MDA-MB-231 breast cancer cell lines compared to the mRNA and protein expressions of biomarkers in the untreated group and individual treatments with TRAIL and TNFα. Here, MAP1LC3A is linked to breast cancer.